JAMA: 2011-02-02, Vol. 305, No. 5, Author in the Room™ Audio Interview
MP3•Episode home
Manage episode 337237124 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Gabriela Schmajuk, MD, author of Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans. Summary Points: 1. One third of Medicare managed care patients diagnosed with rheumatoid arthritis are not receiving disease-modifying antirheumatic drugs. 2. There is variation in disease-modifying antirheumatic drug receipt based on "accidental factors": sociodemographics, geographic location, and health plan. 3. Because disease-modifying antirheumatic drug use is the main way to affect outcomes in rheumatoid arthritis, these patient groups and the physicians treating them are a reasonable target for quality improvement interventions.
…
continue reading
97 episodes